Clinical Trials
2 trialsNCT02937272 2026-04-03
A Study of LY3200882 in Participants With Solid Tumors
Eli Lilly and Company
Phase 1 Active not recruiting
NCT02065362 2026-01-29
TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC
Baylor College of Medicine
Phase 1 Active not recruiting